Laparoscopic adrenalectomy has become increasingly popular because of its m
inimally invasive nature, but guidelines for selection of cases suitable fo
r this surgical procedure have not been established. We report a 52-year-ol
d woman with adrenocortical carcinoma, manifesting as Gushing's syndrome, t
reated with laparoscopic adrenalectomy. The tumour was removed in toto and
had been histologically diagnosed as adrenocortical adenoma, However, the p
atient developed intra-abdominal peritoneal dissemination of carcinoma 15 m
onths after surgery. Review of the histopathological findings of the resect
ed adrenocortical tumour revealed that the neoplasm met five out of nine hi
stological criteria for adrenocortical malignancy, and was diagnosed as adr
enocortical carcinoma. Histopathological examination of the tumour was also
consistent with adrenocortical carcinoma. The patient responded extremely
well to chemotherapy, including carboplatin, etoposide and o,p'-DDD (1,1-di
chlorodiphenyldichloroethane), and a subsequent CT (computed tomography) sc
an 12 months after the start of chemotherapy demonstrated no evidence of di
sease. However, the patient developed neurological impairment, including dy
sarthria, as a side-effect of o,p'-DDD, The patient died of aspiration pneu
monia due to a decreased pharyngeal reflex. Postmortem examination revealed
no foci of residual carcinoma. This case report emphasizes the importance
of excluing possible adrenocortical malignancy in patients considered for l
aparoscopic adrenalectomy, histopathological diagnosis of adrenocortical ma
lignancy and careful monitoring for neurotoxicity during o,p'-DDD treatment
.